Cencora Closes $1.8 Billion Senior Notes Offering
Cencora (NYSE: COR) has successfully closed a public offering of senior notes totaling $1.8 billion. The offering consists of three tranches: $500 million of 4.625% notes due 2027, $600 million of 4.850% notes due 2029, and $700 million of 5.150% notes due 2035.
The proceeds will be used to finance the acquisition of the majority stake in Retina Consultants of America, related fees, and general corporate purposes. The offering was managed by BofA Securities, Citigroup Global Markets, J.P. Morgan Securities, and Wells Fargo Securities.
Cencora (NYSE: COR) ha concluso con successo un'offerta pubblica di obbligazioni senior per un totale di 1,8 miliardi di dollari. L'offerta consiste di tre tranche: 500 milioni di dollari di obbligazioni al 4,625% in scadenza nel 2027, 600 milioni di dollari di obbligazioni al 4,850% in scadenza nel 2029 e 700 milioni di dollari di obbligazioni al 5,150% in scadenza nel 2035.
Il ricavato sar脿 utilizzato per finanziare l'acquisizione della partecipazione di maggioranza in Retina Consultants of America, le spese correlate e scopi aziendali generali. L'offerta 猫 stata gestita da BofA Securities, Citigroup Global Markets, J.P. Morgan Securities e Wells Fargo Securities.
Cencora (NYSE: COR) ha cerrado con 茅xito una oferta p煤blica de notas senior por un total de $1.8 mil millones. La oferta consta de tres tramos: $500 millones de notas al 4.625% con vencimiento en 2027, $600 millones de notas al 4.850% con vencimiento en 2029 y $700 millones de notas al 5.150% con vencimiento en 2035.
Los ingresos se utilizar谩n para financiar la adquisici贸n de la participaci贸n mayoritaria en Retina Consultants of America, los costos relacionados y prop贸sitos corporativos generales. La oferta fue gestionada por BofA Securities, Citigroup Global Markets, J.P. Morgan Securities y Wells Fargo Securities.
Cencora (NYSE: COR)電 齑 18鞏 雼煬 攴滊鞚 瓿犾渼項 毂勱秾 瓿店皽 氇鞚 靹标车鞝侅溂搿 毵堨长鞀惦媹雼. 鞚 氇鞚 靹 臧滌潣 攵勴暊搿 甑劚霅橃柎 鞛堨溂氅: 5鞏 雼煬鞚 4.625% 毂勱秾(毵岅赴 2027雲), 6鞏 雼煬鞚 4.850% 毂勱秾(毵岅赴 2029雲), 攴鸽Μ瓿 7鞏 雼煬鞚 5.150% 毂勱秾(毵岅赴 2035雲)鞛呺媹雼.
氇鞚 韱淀暣 鞏混潃 鞛愱笀鞚 Retina Consultants of America鞚 雼れ垬 歆攵 鞚胳垬, 甏霠 靾橃垬耄 氚 鞚茧皹 須岇偓 鞖╇弰搿 靷毄霅 瓴冹瀰雼堧嫟. 鞚 氇鞚 BofA Securities, Citigroup Global Markets, J.P. Morgan Securities, Wells Fargo Securities鞐 鞚橅暣 甏毽悩鞐堨姷雼堧嫟.
Cencora (NYSE: COR) a r茅ussi 脿 cl么turer une offre publique de titres senior totalisant 1,8 milliard de dollars. L'offre se compose de trois tranches : 500 millions de dollars de titres 脿 4,625% arrivant 脿 茅ch茅ance en 2027, 600 millions de dollars de titres 脿 4,850% arrivant 脿 茅ch茅ance en 2029 et 700 millions de dollars de titres 脿 5,150% arrivant 脿 茅ch茅ance en 2035.
Les fonds seront utilis茅s pour financer l'acquisition de la participation majoritaire dans Retina Consultants of America, les frais connexes et les fins d'entreprise g茅n茅rales. L'offre a 茅t茅 g茅r茅e par BofA Securities, Citigroup Global Markets, J.P. Morgan Securities et Wells Fargo Securities.
Cencora (NYSE: COR) hat erfolgreich ein 枚ffentliches Angebot von Senior Notes im Gesamtwert von 1,8 Milliarden USD abgeschlossen. Das Angebot besteht aus drei Tranchen: 500 Millionen USD von 4,625%-Noten mit F盲lligkeit 2027, 600 Millionen USD von 4,850%-Noten mit F盲lligkeit 2029 und 700 Millionen USD von 5,150%-Noten mit F盲lligkeit 2035.
Die Mittel werden verwendet, um den Erwerb der Mehrheitsbeteiligung an Retina Consultants of America, die damit verbundenen Geb眉hren und allgemeine Unternehmenszwecke zu finanzieren. Das Angebot wurde von BofA Securities, Citigroup Global Markets, J.P. Morgan Securities und Wells Fargo Securities verwaltet.
- Successfully raised $1.8 billion through senior notes offering
- Strategic expansion through planned acquisition of Retina Consultants of America
- Increased long-term debt obligations with interest rates ranging from 4.625% to 5.150%
Insights
Cencora intends to use the net proceeds from the offering to finance the acquisition of the majority of Retina Consultants of America and related fees and expenses, and for general corporate purposes.
The joint book-running managers for the offering were BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC. Cencora filed a final prospectus supplement and an accompanying prospectus with the SEC in connection with the offering of the Notes. Copies of these materials can be made available by contacting: BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street,
This news release shall not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any sale of the Notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Cencora
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than
Cencora鈥檚 Cautionary Note Regarding Forward-Looking Statements
Certain of the statements contained in this press release are 鈥渇orward-looking statements鈥 within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the 鈥淪ecurities Exchange Act鈥). Words such as 鈥渁im,鈥 鈥渁nticipate,鈥 鈥渂elieve,鈥 鈥渃an,鈥 鈥渃ontinue,鈥 鈥渃ould,鈥, 鈥渆stimate,鈥 鈥渆xpect,鈥 鈥渋ntend,鈥 鈥渕ay,鈥 鈥渕ight,鈥 鈥渙n track,鈥 鈥渙pportunity,鈥 鈥減lan,鈥 鈥減ossible,鈥 鈥減otential,鈥 鈥減redict,鈥 鈥減roject,鈥 鈥渟eek,鈥 鈥渟hould,鈥 鈥渟trive,鈥 鈥渟ustain,鈥 鈥渟ynergy,鈥 鈥渢arget,鈥 鈥渨ill,鈥 鈥渨ould鈥 and similar expressions are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These statements are based on management鈥檚 current expectations and are subject to uncertainty and changes in circumstances and speak only as of the date hereof. These statements are not guarantees of future performance and are based on assumptions and estimates that could prove incorrect or could cause actual results to vary materially from those indicated. A more detailed discussion of the risks and uncertainties that could cause our actual results to differ materially from those indicated is included in the 鈥淩isk Factors鈥 and 鈥淢anagement鈥檚 Discussion and Analysis鈥 sections in the Company鈥檚 Annual Report on Form 10-K for the fiscal year ended September 30, 2024 and elsewhere in that report and other reports filed by the Company pursuant to the Securities Exchange Act. The Company undertakes no obligation to publicly update or revise any forward-looking statements, except as required by the federal securities laws.
View source version on businesswire.com:
Bennett S. Murphy
Senior Vice President, Head of Investor Relations & Treasury
610-727-3693
bennett.murphy@cencora.com
Source: Cencora
FAQ
What is the total value of Cencora's (COR) senior notes offering in 2024?
What are the interest rates for Cencora's (COR) different senior notes tranches?
What will Cencora (COR) use the proceeds from the senior notes offering for?
